ALBUQUERQUE, NM, Jan. 31 -- Cell Robotics International Inc. has extended its intellectual property coverage of the Lasette product line by licensing a key patent from BD (formerly Becton, Dickinson and Co.) of Franklin Lakes, N.J. Specific terms and conditions of the agreement were not disclosed. Ronald K. Lohrding, Cell Robotics' president and CEO, said, "We are delighted to have successfully completed this agreement with BD. Combining Cell Robotics' patents on various aspects of laser finger perforation with the license to BD's intellectual property provides us with very strong patent protection for this revolutionary Lasette product line." The hand-held Lasette is the only FDA-cleared medical device that uses a special wavelength of laser light to obtain a capillary blood sample used for glucose readings and clinical blood screening tests.